Dimer Health vs Verily (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two clinical programmes wrapped in software, sold to different buyers for different windows. Dimer runs clinician led transitional care in the days after discharge, which is when readmission risk peaks and support is thinnest, and it is a bounded episode with a measurable endpoint. Verily runs chronic condition management and research programmes for plans, employers and pharmacy benefit managers, with a credible certification set and a better designed privacy structure than most consumer facing arrangements here. If your exposure is readmission penalties, Dimer is aimed at that specific window. If it is a chronic population managed across years, Verily is built for the longer horizon. Neither publishes engagement adjusted outcomes, which is what would show either programme worked rather than selected.

The case for Dimer Health
  • Clinician led transitional care concentrates on the days after discharge, when readmission risk is highest and support is thinnest.
  • A bounded episode with a measurable endpoint makes the programme's effect easier to attribute than ongoing monitoring.
  • For an organisation whose exposure is readmission penalties, the intervention window is the one that matters.
The case for Verily
  • It runs chronic condition management and research programmes for plans, employers and pharmacy benefit managers with a credible certification set.
  • The health privacy structure is better designed than most consumer facing arrangements in this index.
  • Agents triage and escalate members to a clinical team, with commitments published in language a member can read.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Dimer Health and Verily are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Dimer Health Verily
Primary category Remote Monitoring & Chronic Care Remote Monitoring & Chronic Care
Founded 2023 2015
Headquarters Florham Park, New Jersey South San Francisco, California
Website dimerhealth.com verily.com
Attribute Matrix

Side by Side

Axis
D
Dimer Health
V
Verily
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Dimer Health

The AI Health Index awards Dimer Health its top capability grade on Autonomy and Oversight Model and Setting and Specialty Coverage. Set against Verily, Dimer Health grades higher on Setting and Specialty Coverage. Its thinnest published disclosure sits on Model Supply Chain Disclosure and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

Verily

The AI Health Index awards Verily its top capability grade on Autonomy and Oversight Model. Set against Dimer Health, Verily grades higher on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and Security Certifications and Trust Center. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Dimer Health or Verily?

On the axes where the AI Health Index separates them, Dimer Health grades higher on Setting and Specialty Coverage, and Verily grades higher on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and Security Certifications and Trust Center. Verily leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.

Where do Dimer Health and Verily differ most?

The widest separation the AI Health Index records between Dimer Health and Verily is on Setting and Specialty Coverage, where Dimer Health grades A and Verily grades B. That axis sits in the Commercial group, so it should carry the most weight for a buyer whose binding constraint is contracting, scope and what the price actually covers.

Where do Dimer Health and Verily grade the same?

The AI Health Index grades Dimer Health and Verily the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

What have Dimer Health and Verily not disclosed?

At the last review, at least one of Dimer Health and Verily published thin or absent detail on Model Supply Chain Disclosure and AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.

Disclosure

The buyers differ, one selling to health systems carrying readmission exposure and the other to plans, employers and pharmacy benefit managers, so a like for like cost comparison does not exist. Neither publishes engagement adjusted outcomes, which is the figure that separates a programme that worked from one that recruited the already motivated. Verily names its products and agents but not the technology beneath them and publishes no governance framework. Dimer publishes little on security or retention.